Marwa Pharma
We have our own pipeline at Marwa Pharma – Sudan, with OMAP
brands already in production and ready to be launched by the end
of 2020. In two phases, we shall roll out tablets, capsules, and then
liquid dosage forms. Our therapeutic areas include:
Hypertension
Hyperlipidaemia
Diabetes
Antibiotics
NSAIDS
